Ultragenyx Pharmaceutical (RARE) EBT Margin Growth (5y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.00 |
| Dec 31, 2025 | -3,545.00 |
| Sep 30, 2025 | -2,814.00 |
| Jun 30, 2025 | -11,017.00 |
| Mar 31, 2025 | 21,877.00 |
| Dec 31, 2024 | 51,763.00 |
| Sep 30, 2024 | 34,133.00 |
| Jun 30, 2024 | 32,086.00 |
| Mar 31, 2024 | 37,484.00 |
| Dec 31, 2023 | 43,910.00 |
| Sep 30, 2023 | 57,798.00 |
| Jun 30, 2023 | 26,444.00 |
| Mar 31, 2023 | -44,638.00 |
| Dec 31, 2022 | 451,587.00 |
| Sep 30, 2022 | 3.97 Mn |
| Dec 31, 2021 | 142.49 Mn |
| Sep 30, 2021 | 5.84 Mn |
| Jun 30, 2021 | 33.47 Mn |